Fresh analysis indicates that patients who come off blockbuster GLP-1 drugs like Mounjaro or Wegovy can put back on reduced body mass at a significantly accelerated pace than those who halt conventional lifestyle plans.
Published data in a prominent health publication points out that while overweight individuals can lose about a fifth of their body weight while on the medication, the weight is regained at an estimated rate of nearly a kilo each month after stopping.
"Users purchasing such drugs must be cognizant of the danger of quick rebound weight gain when the treatment is stopped," cautioned researcher Dr. Susan Jebb.
Such speed of recovery means a return to starting mass within about one and a half years.
Analyzing Treatments
The research, which looked at dozens of studies involving thousands of patients, compared the effects of these new drugs with older methods.
Scientists emphasize that individuals who lose weight through lifestyle changes alone typically experience a less rapid weight regain—approximately 0.1 kg a month—once they finish.
Explaining the Rapid Rebound
Nutrition scientists suggest the way of the drugs accounts for the amplified rebound.
GLP-1 drugs mimic a body's own chemical called GLP-1, which moderates feelings of fullness.
"Artificially providing GLP-1 concentrations several times higher than the body's typical production may cause the system to generate a reduced amount of its own natural hormone, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher.
"Stopping of this hormone supplement results in appetite is unsuppressed, making excessive eating a significant risk."
A Lifelong Condition?
Medical guidelines advise the jabs for people with weight-linked health risks, alongside recommended diet and exercise modifications.
Professionals contend that, given the significant potential of weight regain, the treatment might need to be life-long.
This opinion is echoed by pharmaceutical companies, who state that the results "emphasize the persistent character of obesity," akin to managing diseases like diabetes.
Patient Testimonies
People who have discontinued the jabs describe a intense resurgence of appetite.
"It was like a trigger activating and I was suddenly ravenous," described one woman.
The struggle is exacerbated if patients have not established sustainable lifestyle or habit changes during treatment.
Widespread Adoption
Survey data suggest that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with interest being substantial.
- Use is higher among women compared to males.
- The 40s and 50s demographic shows the greatest level of interest.
- Many access the drugs through private healthcare rather than the NHS.
In conclusion, experts emphasize that while the jabs are effective tools for weight loss, they are not a permanent solution and maintained weight loss relies on integrated lifestyle support.